NCI's Plan for Clinical Proteomics Initiative Spurs Questions about Sourcing of Patient Samples
August 27, 2010
NCI's Plan for Clinical Proteomics Initiative Spurs Questions about Sourcing of Patient Samples
In particular, George Mason University researcher Emanuel Petricoin expressed concerns about the project's plan to use samples from different patient cohorts for its discovery and verification stages.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Hutch, Broad Teams Publish Comprehensive Methods for MS-Based Biomarker Discovery and Verification
July 29, 2011 / ProteoMonitor - CPTAC, Seoul National University to Test Proteomic Workflows Including MRM-MS in Clinical Setting
February 8, 2013 / ProteoMonitor - Yale Researcher Suggests More Focus on EGFR Isoforms Needed in Development of Antibody-Based Drugs
May 20, 2011 / ProteoMonitor - FDA Official Offers Agency's Take on Protein IVDMIA Mock 510(k) Submissions
January 14, 2011 / ProteoMonitor - Activiomics Inks Deal with UCB; Aims to Raise $1M in Venture Funding Early Next Year
December 10, 2010 / ProteoMonitor